Zkusit zdarma
TScan Therapeutics, Inc.

TScan Therapeutics, Inc.

TCRX
Cena:
 
 
Valuace
70
Růst
20
Zdraví
75
preloader

Finanční výsledky TScan Therapeutics, Inc. (TCRX)

Měna: USD

Ukazatel20252024202320222021
Diluted EPS-1-1.14-1.36-2.75-4.17
Gross Profit10.3M2.8M21M13.5M10.1M
Net Income Attributable to Common Shareholders-129.8M-127.5M-89.2M-66.2M-48.6M
Operating Profit-135.8M-134.8M-93.5M-66.6M-48.6M
Total Revenues10.3M2.8M21M13.5M10.1M